UPC CFI 619/2025
Jul 4, 2025·EP4226941 +1 more · PEGYLATED LIPOSOMES FOR DELIVERY OF IMMUNOGEN-ENCODING RNA
- Case details
- StatusInterim PhaseActionInfringementCategoryMain infringement action
- Parties
- Claimants
- GlaxoSmithKline Biologicals SAOperating co.
Representatives- Tjibbe Douma-Bird & Bird LLP
- Carlos van Staveren-Bird & Bird LLP
Respondents- Moderna Netherlands B.V.Operating co.
- Moderna Biotech Spain SLOperating co.
- Moderna Biotech UK LimitedOperating co.
- Moderna Biotech Distributor UK LtdOperating co.
- Moderna Switzerland GmbHOperating co.
- Moderna Poland Sp. z o.o.Operating co.
- Moderna, Inc.Operating co.
- ModernaTX, Inc.Operating co.
- Moderna Belgium S.R.L.Operating co.
- Moderna France SASUOperating co.
- Moderna Germany GmbHOperating co.
- Moderna Italy S.R.L.Operating co.
- Moderna Portugal Unipessoal LDAOperating co.
- Moderna Sweden ABOperating co.
- Moderna Norway ASOperating co.
Representatives- Gertjan Kuipers-Hogan Lovells International LLP
- Thomas Wolter-Mewburn Ellis LLP
- Division
- The Hague LD
- Technology
- ChemistryPharmaceuticals
- Language
- English
- First decided
- Nov 28, 2025
- Last decision
- Aug 10, 2026
- EPO Opposition
- Thomann, WilliamAdmissible2023-09-06
- SANOFIAdmissible2023-09-06
- Weickmann & Weickmann PartmbBAdmissible2023-09-07
- JG Oppositions LimitedAdmissible2023-09-07
- ModernaTX, Inc.Admissible2025-07-15
- SANOFIAdmissible2025-07-22
- Weickmann & Weickmann Patent- und Rechtsanwälte PartmbBAdmissible2025-07-22
- BioNTech SEAdmissible2025-07-22
- Arrowhouse GmbHAdmissible2025-07-23
| Infringement found | Median days to first decision | |
|---|---|---|
| All UPC | 53% (62/117) | 124 |
| The Hague LD | Locked | Locked |
| Judge Edger Brinkman | Locked | Locked |
| Judge Margot Kokke | Locked | Locked |
| Judge Stefan Schilling | Locked | Locked |
| Judge Martin Schmidt | Locked | Locked |
At the UPC: GlaxoSmithKline Biologicals SA (20 cases)·Moderna Group (20 cases)
This dispute contains 2 other proceedings
3 other defendants litigating the same or a related patent
Start a free trial to see how each one ended.
More cases: The Hague LD·2025
- 2026-08-10InfringementPublic
Summary: The Hague Local Division disposed of revocation counterclaim UPC_CFI_2033/2025 under R. 360 RoP as devoid of purpose, EP4066856 having been finally revoked at the EPO, with GSK bearing Moderna's costs as the unsuccessful party. The decision on Moderna's stay request was postponed, the 2 October 2026 hearing cancelled, and the parties given the opportunity to brief the impact of the forthcoming written TBA decision on divisional EP4226941.
Show the legal issues (4)
- disposal of a counterclaim rendered devoid of purpose (R. 360 RoP)
- stay of proceedings pending EPO opposition/appeal (R. 295 RoP)
- effect of an EPO revocation on a parallel UPC action
- relevance of a revoked parent to the validity of its divisional
- 2026-02-25Infringement ActionPublic
Summary: The Hague Local Division addressed GSK's R.263 application to amend its claim and Moderna's R.9 application to dismiss late-filed submissions in a parallel mRNA vaccine infringement action.
Show the legal issues (2)
- Amendment of claim Rule 263 RoP
- Late-filed submissions Rule 9 RoP
- 2025-11-28Infringement ActionPublic
Summary: The Hague Local Division issued a procedural order under R. 302 RoP addressing a procedural step in proceedings before the court.
Show the legal issues (1)
- Procedural order (R. 302 RoP)
| Document title | Date | Public |
|---|---|---|
| Receipt | 2026-10-05 | Not public |
| Cover sheet | 2026-10-05 | Not public |
| Submission Claimant | 2026-10-05 | Not public |
| Receipt | 2026-10-05 | Not public |
| Cover sheet | 2026-10-05 | Not public |
| Exhibit Defendant | 2026-10-05 | Not public |
| Exhibit Defendant | 2026-10-05 | Not public |
| Exhibit Defendant | 2026-10-05 | Not public |
| Exhibit Defendant | 2026-10-05 | Not public |
| Exhibit Defendant | 2026-10-05 | Not public |